logo-loader
viewAMPEL BioSolutions

AMPEL BioSolutions focused on developing clinical blood test predicts the correct drug for a patient

AMPEL BioSolutions COO Dr Amrie Grammer chatted with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Charlottesville, Virginia-based company can identify drugs for treating lupus patients. According to its website, the company's system can be applied to any disease.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Covid Technologies looking for large growth after being...

Micron Waste Technologies (CSE: MWM- OTC: MICWF) soon to be subsidiary COVID Technologies President Harvey Sidhu joined Steve Darling from Proactive Vancouver to discuss his company being acquired by Micron. Sidhu discusses his company which makes PPE or personal protective equipment....

6 hours, 44 minutes ago

2 min read